Research Domain - Infectious Diseases and Immunity
Alcohol, Tobacco and Other Substances Anthropometrics Bone and Joint Cancer Cancer Outcomes and Survivorship Cardiovascular Demographics Diabetes Environmental Exposures Gastrointestinal Genomic Medicine Implementation Geriatrics Infectious Diseases and Immunity
Neurology Nutrition and Dietary Supplements Obesity Ocular Oral Health Pediatric Development Physical Activity and Physical Fitness Pregnancy Psychiatric Psychosocial Rare Genetic Conditions Reproductive Health Respiratory Skin Smoking Cessation, Harm Reduction and Biomarkers Social Environments Speech, Language and Hearing
Select | Protocol | ID |
---|---|---|
|
#160101 |
|
|
#160801 |
|
|
#160802 |
|
|
#160201 |
|
|
#160401 |
|
|
#160301 |
|
|
#160501 |
|
|
#160901 |
|
|
#160601 |
|
|
#161001 |
|
|
#161101 |
|
|
#161201 |
|
|
#161301 |
|
|
#161401 |
|
|
#161602 |
|
|
#161601 |
|
|
#160701 |
Release Date:
November 12, 2010
Scope of Domain:
Scope Elements | Final Protocols To Toolkit (17) |
---|---|
Personal History of Conditions and Symptoms | Assay for Human Immunodeficiency Virus (HIV) |
Personal History of Conditions and Symptoms | Conditions Relevant to Immune Response - Screener (Child and Adult) |
Personal History of Conditions and Symptoms | Medical History |
Personal History of Conditions and Symptoms | Personal and Family History of Autoimmune and Inflammatory Disorders |
Personal History of Conditions and Symptoms | Personal History of Allergies, Infectious Diseases, and Immunizations (Child and Adult) |
Risk Factors (past and present) | Injection Drug Use |
Risk Factors (past and present) | International Travel History |
Treatments and Procedures (past and present) | Immunizations |
Biological and Physiological Assessments (serum, buffy coat) | Assay for Chlamydia/Gonorrhea |
Biological and Physiological Assessments (serum, buffy coat) | Assay for Cytokine Panel 12 |
Biological and Physiological Assessments (serum, buffy coat) | Assay for Hepatitis B |
Biological and Physiological Assessments (serum, buffy coat) | Assay for Hepatitis C |
Biological and Physiological Assessments (serum, buffy coat) | Assay for Herpes Simplex Type 1 and 2 |
Biological and Physiological Assessments (serum, buffy coat) | Assay for Human Leukocyte Antigen (HLA) Genotyping |
Biological and Physiological Assessments (serum, buffy coat) | Assay for Syphilis |
Working Group Roster:
WG Members:
Richard Kaslow, MD, MPH, Chair University of Alabama, Birmingham Birmingham, AL |
Carol Heilman, PhD National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, MD |
David Karp, MD, PhD University of Texas, Southwestern Medical Center Dallas, TX |
Kathy Moser, PhD Oklahoma Medical Research Foundation Oklahoma City, OK |
Hans D. Ochs, MD University of Washington Children's Hospital Seattle, WA |
Jerry Winkelstein, MD Johns Hopkins University Baltimore, MD |
Christopher Woods, MD, MPH Duke University Durham, NC |
SC Liaison, WG Manager and WG Supervisor:
Jonathan L. Haines, PhD, SC Liaison Case Western Reserve University Cleveland, OH |
Anne-Lyne McCalla, MPH, RD, WG Manager RTI International Research Triangle Park, NC |
Lisa Strader, MPH, WG Supervisor RTI International Research Triangle Park, NC |
Infectious Diseases and Immunity Supplemental Information includes:
There is no supplemental information for this domain.